These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7077200)

  • 1. Multiple risk factor intervention for prevention of coronary artery disease.
    Watkins LO
    J Med Assoc Ga; 1982 Feb; 71(2):139-41. PubMed ID: 7077200
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of coronary heart disease: the last 20 years.
    Stamler J
    Am J Cardiol; 1981 Mar; 47(3):722-35. PubMed ID: 7008572
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of preventive cardiology on coronary artery disease.
    Elford RW; Yeo M
    CMAJ; 1988 Oct; 139(8):719-24. PubMed ID: 3139276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Oslo study. Coronary risk factors, socioeconomy and prevention].
    Leren P
    Wien Med Wochenschr; 1982; 132 Spec No 2():15-8. PubMed ID: 7168182
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of coronary heart disease.
    World Health Organ Tech Rep Ser; 1982; 678():1-53. PubMed ID: 6812294
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Community" treatment in arterial hypertension. Preliminary trials in the Rome Project for the Prevention of Coronary Cardiopathy].
    Menotti A; Signoretti P; Cianti C; Angelico F; Bucci A; Clemente P; Giuliani A; Trezzini C; Ricci G
    Clin Ter; 1977 Jul; 82(1):31-44. PubMed ID: 902462
    [No Abstract]   [Full Text] [Related]  

  • 9. The multiple risk factor intervention trial (MRFIT): implications for nurses.
    Ackerman AM; Froman D; Becker DM
    Prog Cardiovasc Nurs; 1987; 2(3):92-9. PubMed ID: 3313379
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary risk factor intervention: characteristics associated with change.
    Eaker ED; Benfari RC; Reed RB
    J Clin Psychol; 1982 Oct; 38(4):703-17. PubMed ID: 7174801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
    Chiuve SE; McCullough ML; Sacks FM; Rimm EB
    Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT).
    Farrand ME; Mojonnier L
    J Am Diet Assoc; 1980 Apr; 76(4):347-51. PubMed ID: 7391467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary risk factors 6-12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1994 Nov; 161(9):536-7. PubMed ID: 7968753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the separation of the intervention effects of diet and antismoking advice on the incidence of major coronary events in coronary high risk men. The Oslo Study.
    Holme I
    J Oslo City Hosp; 1982; 32(3-4):31-54. PubMed ID: 7062163
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive therapy and coronary heart disease: significance of the effect of concomitant cardiovascular risk factors].
    Huber K; Wein W; Hornykewycz S; Zehetgruber M; Rauscha F
    Acta Med Austriaca; 1995; 22(3):48-51. PubMed ID: 8571751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of ischemic cardiopathies].
    Denolin H
    Rev Med Suisse Romande; 1981 Jan; 101(1):3-7. PubMed ID: 7221319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toward a better application of the prevention of coronary diseases in the hospital].
    Gomez D
    Soins Cardiol; 1983 Sep; (6-7):53-63. PubMed ID: 6558858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.